3rd Quarter - Report
W STRATEGIES, LLC for GILEAD SCIENCES, INC.
Firm
Client
Income
$60,000
Expenses
—
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Medicare/Medicaid MMM
FY'22 Budget Reconciliation including H.R.3: Elijah E. Cummings Lower Drug Costs Now Act. And H.R.19: Lower Costs, More Cures Act of 2021. S.2911: Seniors Prescription Drug Relief Act.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DARREN WILLCOX | — |
Trade (domestic/foreign) TRD
Issues related to Covid-19 vaccines and TRIPS at WTO.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DARREN WILLCOX | — |
Health Issues HCR
Education around therapies for COVID-19. Education around copay accumulators.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DARREN WILLCOX | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.